We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSN icon
651
Tyson Foods
TSN
$20.2B
$527K 0.01%
6,498
+2,998
+86% +$229K
HBI
652
DELISTED
Hanesbrands
HBI
$520K 0.01%
24,861
– –
RGLS
653
DELISTED
Regulus Therapeutics
RGLS
$520K 0.01%
4,167
-833
-17% -$105K
NGD
654
DELISTED
New Gold Inc
NGD
$516K 0.01%
+156,864
New +$527K
BRO icon
655
Brown & Brown
BRO
$22.9B
$515K 0.01%
20,000
– –
HAIN icon
656
Hain Celestial
HAIN
$47.8M
$509K 0.01%
12,000
– –
AVDL
657
DELISTED
Avadel Pharmaceuticals
AVDL
$508K 0.01%
62,000
-49,000
-44% -$459K
MSCI icon
658
MSCI
MSCI
$40B
$506K 0.01%
4,000
– –
SKT icon
659
Tanger
SKT
$4.82B
$504K 0.01%
+19,000
New +$470K
BHF icon
660
Brighthouse Financial
BHF
$3.63B
$500K 0.01%
8,524
+960
+13% +$56.8K
FBIN icon
661
Fortune Brands Innovations
FBIN
$6.12B
$496K 0.01%
8,472
-62,218
-88% -$3.53M
WRI
662
DELISTED
Weingarten Realty Investors
WRI
$493K 0.01%
+15,000
New +$486K
ACHC icon
663
Acadia Healthcare
ACHC
$3.17B
$489K 0.01%
15,000
+5,000
+50% +$173K
AVY icon
664
Avery Dennison
AVY
$12.3B
$488K 0.01%
4,245
-1,878
-31% -$203K
QRVO icon
665
Qorvo
QRVO
$7.63B
$487K 0.01%
+7,315
New +$533K
GXP
666
DELISTED
Great Plains Energy Incorporated
GXP
$485K 0.01%
15,054
– –
CMG icon
667
Chipotle Mexican Grill
CMG
$40.8B
$480K 0.01%
82,950
– –
NFG icon
668
National Fuel Gas
NFG
$7.84B
$480K 0.01%
8,734
-25,672
-75% -$1.47M
TCON
669
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$479K 0.01%
715
– –
CBRL icon
670
Cracker Barrel
CBRL
$1.2B
$477K 0.01%
3,000
– –
OHI icon
671
Omega Healthcare
OHI
$15.4B
$468K 0.01%
+17,000
New +$491K
SIX
672
DELISTED
Six Flags Entertainment Corp.
SIX
$466K 0.01%
+7,000
New +$448K
FLO icon
673
Flowers Foods
FLO
$1.64B
$463K 0.01%
+24,000
New +$461K
CLGX
674
DELISTED
Corelogic, Inc.
CLGX
$462K 0.01%
10,000
– –
AES icon
675
AES
AES
$10.6B
$461K 0.01%
42,592
-14,047
-25% -$152K
25 26
27
28 29

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.